References
- Greer DM. Mechanisms of injury in hypoxicischemic encephalopathy : implications to therapy. Semin Neurol. 2006;26:373-379. https://doi.org/10.1055/s-2006-948317
- Hopkins RO, Tate DF, Bigler ED. Anoxic versus traumatic brain injury: amount of tissue loss, not etiology, alters cognitive and emotional function. Neuropsychology. 2005;19:233-242. https://doi.org/10.1037/0894-4105.19.2.233
- Hopkins RO, Bigler ED. Neuroimaging of anoxic injury:implications for neurorehabilitation. Neuro-Rehabilitation. 2012;31:319-329.
- Lu-Emerson C, Khot S. Neurological sequelae of hypoxicischemic brain injury. NeuroRehabilitation. 2010;26:35-45. https://doi.org/10.3233/nre-2010-0534
- Fitzgerald A, Aditya H, Prior A, McNeill E, Pentland B. Anoxic brain injury: Clinical patterns and functional outcomes. A study of 93 cases. Brain Inj. 2010;24:1311-1323. https://doi.org/10.3109/02699052.2010.506864
- Moulaert VR, Verbunt JA, van Heugten CM, Wade DT. Cognitive impairments in survivors of outof-hospital cardiac arrest: a systematic review. Resuscitation. 2009;80:297-305. https://doi.org/10.1016/j.resuscitation.2008.10.034
- Harukuni I, Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia. Neurol Clin. 2006;24:1-21. https://doi.org/10.1016/j.ncl.2005.10.004
- Venkat P, Chopp M, Chen J. Models and mechanisms of vascular dementia. Exp Neurol. 2015;272:97-108. https://doi.org/10.1016/j.expneurol.2015.05.006
- Kim YH, Kim LW, Chung DO. Pharmacotherapy of Vascular Dementia. J Korean Geriatr Psychiatry. 1999;3(2):199-128.
- Shibayama H, Kasahara Y, Kobayashi H. Prevalence of dementia in a japanese elderly population. Acta Psychiatr Scand. 1986;74(2):144-151. https://doi.org/10.1111/j.1600-0447.1986.tb10598.x
- Skoog I. Vascular aspects in Alzheimer's disease. J Neural Transm Suppl. 2000;59:37-43.
- Lee JH. Treatment of Vascular Dementia: A comprehensive Review. J Korea Neurol Assoc. 2003;21(5):445-454.
- Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol. 1993;33:494-501. https://doi.org/10.1002/ana.410330513
- Roberson MR, Kolasa K, Parsons DS, Harrell LE. Cholinergic denervation and sympathetic ingrowth result in persistent changes in hippocampal muscarinic receptors. Neuroscience. 1997;80:413-418. https://doi.org/10.1016/S0306-4522(97)00153-X
- Man SC, Chan KW, Lu JH, Durairajan SS, Liu LF, Li M. Systemic review on the efficacy and safety of herbal medicines for vascular dementia. Evi- Based Com and Alt Med. 2012;2012:426215. https://doi.org/10.1155/2012/426215
- Han SH. Novel pharmacotherapies for Alzheimer's disease. J Korean Med Assoc. 2009;52(11):1059-1068. https://doi.org/10.5124/jkma.2009.52.11.1059
- Ma W, Wang KJ, Cheng CS, Yan GQ, Lu WL, Ge JF, Cheng YX, Li N. Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy. J Ethnopharmacol. 2014;153(3):840-845. https://doi.org/10.1016/j.jep.2014.03.051
- Kang DG, Choi DH. Endothelial NO/cGMP-dependent vascular relaxation of cornuside isolated from the fruit of Cornus officinalis. Planta Med. 2007;73(14):1436-1440. https://doi.org/10.1055/s-2007-990243
- Kim SH, Kim BK, Lee YC. Effects of Corni fructus on ovalbumin-induced airway inflammation and airway hyper-responsiveness in a mouse model of allergic asthma. J Inflamm (Lond). 2012;9(1):9. https://doi.org/10.1186/1476-9255-9-9
-
Hwang BH, Kwon DH, Choi EO, Kim MY, Ahn KI, Ji SY, Kim JS, Kim KI, Park NJ, Kim BH, Kim GY, Hong SH, Park C, Jeong JS, Choi YH. Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing
$5{\alpha}$ -reductase and androgen receptor expression in rats. Nutr Res Pract. 2018; 12(5):378-386. https://doi.org/10.4162/nrp.2018.12.5.378 - Jo HG, Kang HJ, Go YJ, Park JW, Park SG, Jung PS, Lee SY, Sul JU, Jung MY, Moon YH. Tendency of Korean herbal medicine prescriptions used for dementia in Korean experimental researches-Mainly about domestic dissertations for a degree-J Korean Medicine Rehabilitation. 24(4):2288-4114.
- May BH, Lu C, Bennett L, Hugel HM, Xue CC. Evaluating the traditional Chinese literature for herbal formulae and individual herbs used for age-related dementia and memory impairment. Biogerontology. 2012;13(3):299-312. https://doi.org/10.1007/s10522-012-9375-6
-
Sangha JS, Sun X, Wally OS, Zhang K, Ji X, Wang Z, et al. Liuwei Dihuang (LWDH), a traditional Chinese medicinal formula, protects against
${\beta}$ -amyloid toxicity in transgenic Caenorhabditis elegans. PLoS One. 2012;7(8):e43990. https://doi.org/10.1371/journal.pone.0043990 - Wang J, Yao K, Yang X, Liu W, Feng B, Ma J, Du X, Wang P, Xiong X. Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evid-Based Complement Alternat Med. 2012;2012:714805.
- Choi BM. Effect of YkJeungJiHwangTang (YJJHT) on inhibitions of impairment of learning and memory and acetylcholinerase in amnesia mice. Graduate School of Daejoen University. 2001.
- Song HS. Effect on anti-Alzheimer's disease by Jeonmaedan in CT-105 overexpressed SK-N-SH cell Lines. Graduate School of Daeguhaany University. 2003.
- Kim KH. The effects of Yukmijihwang-tang (UJT) on Dementia induced by focal brain ischemic injury in rats. Graduate School of Dongshin University. 2005.
- Lee KY. The anti-dementia effects of Kukijiwhangtang on improvement memory retention and suppression of ChAT and AchE activities in rat cerebrum. Graduate School of Kyunghee University. 2005.
- Wu CR, Lin LW, Wang WH, Hsieh MT. The ameliorating effects of LiuWei Dihuang Wang on cycloheximide- induced impairment of passive avoidance performance in rats. J Ethnopharmacol. 2007;113(1):79-84. https://doi.org/10.1016/j.jep.2007.05.003
- Hsieh MT, Cheng SJ, Lin LW, Wang WH, Wu CR. The ameliorating effects of acute and chronic administration of LiuWei Dihuang Wang on learning performance in rodents. Biol Pharm Bull. 2003;26(2):156-61. https://doi.org/10.1248/bpb.26.156
-
Sangha JS, Sun X, Wally OS, Zhang K, Ji X, Wang Z, Wang Y, Zidichouski J, Prithiviraj B, Zhang J. Liuwei Dihuang (LWDH), a traditional Chinese medicinal formula, protects against
${\beta}$ -amyloid toxicity in transgenic Caenorhabditis elegans. PLoS One. 2012;7(8): e43990. https://doi.org/10.1371/journal.pone.0043990 - Roth S, Liesz A. Stroke research at the crossroads - where are we heading? Swiss Med Wkly. 2016;146:w14329.
- Chamorro A, Dirnagl U, Urra X, Planas AM. Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol. 2016;15(8):869-881. https://doi.org/10.1016/S1474-4422(16)00114-9
- Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2:43-53. https://doi.org/10.1016/S1474-4422(03)00266-7
- Kim YS. Integrated clinical approach to stroke. Seoul: Seowondang. 1997:303-8,317-29.
- Cucchiara B, Ross M. Transient ischemic attack: risk stratification and treatment. Ann Emereg Med. 2008;52:S27-39. https://doi.org/10.1016/j.annemergmed.2008.05.019
- Barlow SJ. Identifying the brain regions associated with acute spasticity in patients diagnosed with an ischemic stroke. Somatosens Mot Res. 2016:33(2):104-111. https://doi.org/10.1080/08990220.2016.1197114
- Shino A, Tajima Y, Takuwa H, Masamoto K, Taniguchi J, Wakizaka H,Kokuryo D, Urushihata T, Aoki I, Kanno I, Tomita Y, Suzuki N, Ikoma Y, Ito H. Long-term effects of cerebral hypoperfusion on neural density and function using misery perfusion animal model. Sci Rep 2016;6:25072. https://doi.org/10.1038/srep25072
- Zuloaga KL, Zhang W, Yeiser LA, Stewart B, Kukino A, Nie X, Roese NE, Grafe MR, Pike MM, Raber J, Alkayed NJ. Neurobehavioral and imaging correlates of hippocampal atrophy in a mouse model of vascular cognitive impairment. Transl Stroke Res. 2015;6(5):390-398. https://doi.org/10.1007/s12975-015-0412-z
- Zhang Y, Pizzute T, Pei M. A review of crosstalk between MAPK and Wnt signals and its impact on cartilage regeneration. Cell Tissue Res. 2014;358(3):633-649. https://doi.org/10.1007/s00441-014-2010-x
- Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600-604. https://doi.org/10.3109/10799893.2015.1030412
- Zhou J, Du T, Li B, Rong Y, Verkhratsky A, Peng L: Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion. ASN Neuro 2015, 7(5).
- Liu R, Tang JC, Pan MX, Zhuang Y, Zhang Y, Liao HB, Zhao D, Lei Y, Lei RX, Wang S, Liu AC, Qin XP, Chen J, Zhang ZF, Wan Q. ERK 1/2 activation mediates the neuroprotective effect of BpV(pic) in focal cerebral ischemia-reperfusion injury. Neurochem Res. 2018;43(7):1424-1438. https://doi.org/10.1007/s11064-018-2558-z
- Yang S, Zhou G, Liu H, Zhang B, Li J, Cui R, Du Y. Protective effects of p38 MAPK inhibitor SB202190 against hippocampal apoptosis and spatial learning and memory deficits in a rat model of vascular dementia. Biomed Res Int. 2013;2013:215798.
- Schmidt-Kastner R: Genomic approach to selective vulnerability of the hippocampus in brain ischemia-hypoxia. Neuroscience 2015, 309:259-279. https://doi.org/10.1016/j.neuroscience.2015.08.034
- Spencer SJ, Mouihate A, Pittman QJ. Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation. Stroke. 2007;38(5):1570-1577. https://doi.org/10.1161/STROKEAHA.106.476507
- Vargas-Restrepo F, Sabogal-Guaqueta AM, Cardona-Gomez GP. Quercetin ameliorates inflammation in CA1 hippocampal region in aged triple transgenic Alzheimer s disease mice model. Biomedica. 2018;38:69-76. https://doi.org/10.7705/biomedica.v38i0.3507